+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cannabidiol Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • PDF Icon

    Report

  • 400 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 6253506
The global cannabidiol market was valued at USD 8.48 Billion in 2025, driven by the increasing legalisation of marijuana and its widespread application across various industries. It is expected to grow at a CAGR of 19.40% between 2026-2035, reaching a value of USD 49.94 Billion by 2035.

Market Size & Forecast

  • Market Size in 2025: USD 8.48 Billion
  • Projected Market Size in 2035: USD 49.94 Billion
  • CAGR from 2026 to 2035: 19.40%

Cannabidiol Market Overview

Cannabidiol, also known as CBD, is an active ingredient found in the cannabis plant that is not addictive. The cannabis plant is also known as hemp or cannabis sativa. It has numerous health benefits including helping reduce PTSD symptoms, easing diabetic complications, treating opioid addiction, offsetting depression and anxiety, protecting against neurological diseases, relieving pain, and alleviating ALS symptoms.

Cannabidiol Market Growth Drivers

Pharmaceutical Advancements Driving Global Cannabidiol Market Growth

The rising demand for pharmaceutical-grade cannabinoid products and expanding regulatory support for cannabinoids drive the cannabidiol market globally. In November 2024, Vantage Hemp Co. announced the commercial launch of its pharmaceutical-grade CBG isolate, manufactured in a certified GMP facility with cGMP compliance. Alongside this launch, Vantage made strides in Brazil by validating a client’s formula under ANVISA’s RDC 327 framework and applying for ANVISA Good Manufacturing Practices Certification. These developments set new industry standards and expand access to compliant cannabinoid products, positioning Vantage to significantly impact market growth during the forecast period.

Innovative Drug Formats to Boost Cannabidiol Market Value

The increasing focus on enhanced bioavailability and consumer-friendly drug delivery systems is reshaping the cannabidiol market. In June 2024, dsm-firmenich introduced CBtru®, an advanced CBD drug product intermediate designed for oral solid dosage formats, including tablets and chewables. This IP-protected product enables higher drug loading and improved bioavailability, revolutionising patient-friendly CBD-based therapies. By enabling development of orally disintegrating tablets with superior functionality, CBtru® enhances therapeutic outcomes and convenience. These advancements are poised to drive market development, with dsm-firmenich setting benchmarks in cannabinoid innovation and expanding opportunities for CBD’s adoption in mainstream healthcare solutions.

Cannabidiol Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Consumer Awareness and Demand Fuel Market Growth

As global awareness of cannabidiol (CBD) increases, consumer interest in its potential health benefits is driving the growth of the CBD market. This trend is particularly prominent in regions where health-conscious consumers are seeking natural alternatives to traditional pharmaceuticals. CBD’s perceived advantages, including pain relief, anxiety reduction, and anti-inflammatory properties, have fueled its demand across a range of sectors, from wellness and skincare to food and beverages. With more research and consumer education initiatives, this trend is expected to significantly expand CBD market share worldwide, attracting both new and returning customers.

Increasing Regulatory Approvals Enhance Product Accessibility and Cannabidiol Market Value

The legal landscape for cannabidiol products has evolved considerably, with many countries either decriminalizing or legalizing CBD for both medicinal and recreational use. Governments worldwide are introducing clear guidelines and regulations, which contribute to market development by boosting consumer confidence and ensuring product safety. This regulatory clarity is encouraging more companies to enter the market, thus driving competition and innovation. As more regions align with global standards, the CBD market’s global expansion and mainstream acceptance are anticipated to continue at a rapid pace, unlocking new opportunities in emerging markets.

Expansion of Diverse CBD Products Drives Cannabidiol Market Growth

The diversification of cannabidiol-based products has become a key trend in market development. Beyond traditional oils and tinctures, CBD is now found in a wide variety of products, including skincare, beverages, edibles, pet care items, and even clothing. As companies expand their product lines, they are reaching new customer demographics and tapping into various industries such as cosmetics, fitness, and food. This expanding product range allows businesses to meet the evolving needs of different consumer groups, thus boosting market growth and creating new revenue streams in the ever-expanding cannabidiol space.

Increased Investments and Strategic Partnerships to Effect Cannabidiol Market Size Positively

Investment in the cannabidiol sector has surged in recent years as both public and private investors recognize the immense market potential. This influx of capital has supported innovations, product enhancements, and the scaling of production capabilities. Additionally, many CBD companies are entering strategic partnerships with established pharmaceutical, wellness, and food industry leaders to broaden distribution channels and accelerate product adoption. As these collaborations grow, they drive the global cannabidiol market's value upward, allowing for better integration of CBD into mainstream consumer lifestyles and expanding its overall market footprint.

Cannabidiol Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Source

  • Hemp
  • Marijuana

Market Breakup by Sales Channel

  • Business to Business (B2B)
  • Business to Consumer (B2C)

Market Breakup by End User

  • Medical
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
  • Personal Use
  • Pharmaceuticals
  • Wellness
  • Food and Beverages
  • Personal Care and Cosmetics
  • Nutraceuticals
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Cannabidiol Market Share

Market Segmentation by Source to Undergo Noticeable Growth

The hemp segment dominates the market due to its lower THC content, making it widely accepted for therapeutic and wellness applications. Legalisation and regulatory support for hemp-derived products across various countries further boost its adoption. Hemp is cost-effective to cultivate, ensuring a consistent supply for manufacturers. The rising demand for CBD in wellness products like cosmetics and nutraceuticals drives future growth. With its versatility and broader acceptance in legal markets, the hemp segment is poised to drive market growth during the forecast period, solidifying its position as the primary source for CBD production globally.

B2C Channel to Lead the Cannabidiol Market Segmentation by Sales Channel

The business-to-consumer (B2C) segment holds a significant share of the market, fueled by the increasing preference for online shopping and direct retail sales. E-commerce platforms offer consumers convenient access to a wide range of CBD products, complete with detailed product information and competitive pricing, making it easier for people to explore new offerings. A notable development occurred in June 2024, when Curaleaf Holdings Inc., a global leader in cannabis products, launched a new line of hemp-derived THC products under its Select and Zero Proof brands. These products became available for direct consumer orders via Curaleaf’s new online platform as well. This move underscores the growing importance of the B2C channel, as it provides direct access to Farm Bill-compliant, hemp-derived products.

The surge in wellness and self-care trends also plays a pivotal role, with more individuals seeking CBD for personal health. As digital marketing strategies improve and access to CBD products becomes more seamless, the B2C segment will continue to drive market expansion and enhance consumer adoption worldwide.

Rising Application in the Wellness Sector is Set to Elevate Cannabidiol Market Value

The wellness segment is expected to lead the market by end user, driven by increasing consumer interest in CBD-infused products for relaxation, skincare, and dietary health. Applications in food and beverages, personal care, and nutraceuticals dominate, with CBD’s therapeutic benefits enhancing its appeal. Rising disposable incomes and a focus on natural remedies propel growth in this segment. Manufacturers are innovating with novel product formats, meeting diverse consumer demands. As wellness trends continue to rise globally, the segment is expected to expand further, elevating the overall market value of cannabidiol in the forecast period.

Cannabidiol Market Analysis by Region

North America is expected to hold a significant share of the market due to its early legalisation of CBD across various states, creating a mature regulatory framework. The region boasts a robust network of manufacturers, distributors, and retailers, supported by advanced agricultural practices for hemp cultivation. Consumer awareness of CBD’s therapeutic and wellness benefits is notably high, driving demand across personal care, pharmaceuticals, and nutraceuticals. Additionally, significant investments in research and product innovation by North American companies contribute to the market’s expansion. The region’s focus on developing high-quality, diverse CBD products ensures its dominance and paves the way for sustained growth in the forecast period.

Leading Players in the Cannabidiol Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Charlotte’s Web Inc.

Established in 2014 and based in Colorado, Charlotte’s Web Inc. is a leading wellness and fitness company committed to creating a healthier world. The company is renowned for its high-quality, full-spectrum CBD products that aim to improve individuals’ well-being. With a focus on wellness, Charlotte’s Web offers a wide range of products, including CBD oils, gummies, capsules, and topicals, designed to support daily health and fitness routines. The company prioritizes transparency in sourcing and manufacturing, with all products undergoing rigorous third-party testing to ensure quality and consistency. Charlotte’s Web has become a trusted brand among consumers seeking natural alternatives for pain relief, anxiety management, and overall wellness.

Medical Marijuana, Inc.

Founded in 2003 and headquartered in Oregon, Medical Marijuana, Inc. was the first publicly traded company to be legally licensed for hemp and cannabis-based health and wellness products. As a pioneer in the industry, the company has expanded its portfolio to include CBD oils, tinctures, edibles, and skincare products. Medical Marijuana, Inc. focuses on providing safe, high-quality cannabis products and is dedicated to educating consumers about the benefits of hemp-based wellness solutions. Its brands, such as HempMeds and Real Scientific Hemp Oil (RSHO), have become some of the most recognized names in the CBD sector, with a mission to bring the benefits of cannabis to a global market.

CV Sciences Inc.

Founded in 2010 and headquartered in California, CV Sciences Inc. combines science and nature to improve people’s quality of life. As an American company, CV Sciences has developed a reputation for creating research-based CBD solutions that are safe, effective, and backed by scientific evidence. The company’s products, including CBD oils, capsules, and topicals, are formulated with high-quality, non-GMO hemp extracts. CV Sciences is dedicated to advancing the understanding of CBD through clinical research, ensuring that its offerings provide tangible health benefits. With a focus on both wellness and education, CV Sciences strives to make CBD products accessible and reliable for consumers worldwide.

Endoca BV

Endoca BV, established in 2010 and headquartered in the Netherlands, is a key player in the international CBD market. Known for its commitment to sustainability and high-quality standards, Endoca offers a broad range of organic CBD products, including oils, capsules, skincare items, and raw hemp extracts. The company takes a rigorous approach to quality assurance, with each batch of products undergoing extensive testing to ensure purity, potency, and safety. Endoca’s commitment to environmentally friendly practices includes using sustainable farming techniques and minimizing the carbon footprint of its operations. Through its dedication to natural, eco-conscious products, Endoca has garnered a loyal customer base and established itself as a trusted name in the wellness sector.

Other key players in the market include Gaia Herbs, Inc., CBD Store, Medterra CBD, LLC, Anthology Brands, The CBDistillery, and NuLeaf Naturals, LLC.

Key Questions Answered in the Cannabidiol Market

  • What was the global cannabidiol market value in 2025?
  • What is the cannabidiol market forecast outlook for 2026-2035?
  • What is market segmentation based on source?
  • What is market breakup based on sales channel?
  • What is market segmentation based on end user?
  • What are the major factors aiding the cannabidiol market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major cannabidiol market trends?
  • Which source will lead the market segment?
  • Which end user will lead the market segment?
  • Who are the key players involved in the cannabidiol market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cannabidiol Market Overview
3.1 Global Cannabidiol Market Historical Value (2019-2025)
3.2 Global Cannabidiol Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Cannabidiol Market Landscape*
5.1 Global Cannabidiol Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Cannabidiol Market: Product/Service Landscape
5.2.1 Analysis by Source
6 Global Cannabidiol Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Cannabidiol Market Segmentation (219-2035)
7.1 Global Cannabidiol Market (2019-2035) by Source
7.1.1 Market Overview
7.1.2 Hemp
7.1.3 Marijuana
7.2 Global Cannabidiol Market (2019-2035) by Sales Channel
7.2.1 Market Overview
7.2.2 Business to Business (B2B)
7.2.3 Business to Consumer (B2C)
7.3 Global Cannabidiol Market (2019-2035) by End User
7.3.1 Market Overview
7.3.2 Medical
7.3.2.1 Chronic Pain
7.3.2.2 Mental Disorders
7.3.2.3 Cancer
7.3.2.4 Others
7.3.3 Personal Use
7.3.4 Pharmaceuticals
7.3.5 Wellness
7.3.5.1 Food & Beverages
7.3.5.2 Personal Care & Cosmetics
7.3.5.3 Nutraceuticals
7.3.5.4 Others
7.4 Global Cannabidiol Market (2019-2035) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Cannabidiol Market (219-2035)
8.1 North America Cannabidiol Market (2019-2035) by Source
8.1.1 Market Overview
8.1.2 Hemp
8.1.3 Marijuana
8.2 North America Cannabidiol Market (2019-2035) by Sales Channel
8.2.1 Market Overview
8.2.2 Business to Business (B2B)
8.2.3 Business to Consumer (B2C)
8.3 North America Cannabidiol Market (2019-2035) by End User
8.3.1 Market Overview
8.3.2 Medical
8.3.2.1 Chronic Pain
8.3.2.2 Mental Disorders
8.3.2.3 Cancer
8.3.2.4 Others
8.3.3 Personal Use
8.3.4 Pharmaceuticals
8.3.5 Wellness
8.3.5.1 Food & Beverages
8.3.5.2 Personal Care & Cosmetics
8.3.5.3 Nutraceuticals
8.3.6 Others
8.4 North America Cannabidiol Market (2019-2035) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Cannabidiol Market (219-2035)
9.1 Europe Cannabidiol Market (2019-2035) by Source
9.1.1 Market Overview
9.1.2 Hemp
9.1.3 Marijuana
9.2 Europe Cannabidiol Market (2019-2035) by Sales Channel
9.2.1 Market Overview
9.2.2 Business to Business (B2B)
9.2.3 Business to Consumer (B2C)
9.3 Europe Cannabidiol Market (2019-2035) by End User
9.3.1 Market Overview
9.3.2 Medical
9.3.2.1 Chronic Pain
9.3.2.2 Mental Disorders
9.3.2.3 Cancer
9.3.2.4 Others
9.3.3 Personal Use
9.3.4 Pharmaceuticals
9.3.5 Wellness
9.3.5.1 Food & Beverages
9.3.5.2 Personal Care & Cosmetics
9.3.5.3 Nutraceuticals
9.3.6 Others
9.4 Europe Cannabidiol Market (2019-2035) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Cannabidiol Market (219-2035)
10.1 Asia Pacific Cannabidiol Market (2019-2035) by Source
10.1.1 Market Overview
10.1.2 Hemp
10.1.3 Marijuana
10.2 Asia Pacific Cannabidiol Market (2019-2035) by Sales Channel
10.2.1 Market Overview
10.2.2 Business to Business (B2B)
10.2.3 Business to Consumer (B2C)
10.3 Asia Pacific Cannabidiol Market (2019-2035) by End User
10.3.1 Market Overview
10.3.2 Medical
10.3.2.1 Chronic Pain
10.3.2.2 Mental Disorders
10.3.2.3 Cancer
10.3.2.4 Others
10.3.3 Personal Use
10.3.4 Pharmaceuticals
10.3.5 Wellness
10.3.5.1 Food & Beverages
10.3.5.2 Personal Care & Cosmetics
10.3.5.3 Nutraceuticals
10.3.6 Others
10.4 Asia Pacific Cannabidiol Market (2019-2035) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Cannabidiol Market (219-2035)
11.1 Latin America Cannabidiol Market (2019-2035) by Source
11.1.1 Market Overview
11.1.2 Hemp
11.1.3 Marijuana
11.2 Latin America Cannabidiol Market (2019-2035) by Sales Channel
11.2.1 Market Overview
11.2.2 Business to Business (B2B)
11.2.3 Business to Consumer (B2C)
11.3 Latin America Cannabidiol Market (2019-2035) by End User
11.3.1 Market Overview
11.3.2 Medical
11.3.2.1 Chronic Pain
11.3.2.2 Mental Disorders
11.3.2.3 Cancer
11.3.2.4 Others
11.3.3 Personal Use
11.3.4 Pharmaceuticals
11.3.5 Wellness
11.3.5.1 Food & Beverages
11.3.5.2 Personal Care & Cosmetics
11.3.5.3 Nutraceuticals
11.3.6 Others
11.4 Latin America Cannabidiol Market (2019-2035) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Cannabidiol Market (219-2035)
12.1 Middle East and Africa Cannabidiol Market (2019-2035) by Source
12.1.1 Market Overview
12.1.2 Hemp
12.1.3 Marijuana
12.2 Middle East and Africa Cannabidiol Market (2019-2035) by Sales Channel
12.2.1 Market Overview
12.2.2 Business to Business (B2B)
12.2.3 Business to Consumer (B2C)
12.3 Middle East and Africa Cannabidiol Market (2019-2035) by End User
12.3.1 Market Overview
12.3.2 Medical
12.3.2.1 Chronic Pain
12.3.2.2 Mental Disorders
12.3.2.3 Cancer
12.3.2.4 Others
12.3.3 Personal Use
12.3.4 Pharmaceuticals
12.3.5 Wellness
12.3.5.1 Food & Beverages
12.3.5.2 Personal Care & Cosmetics
12.3.5.3 Nutraceuticals
12.3.6 Others
12.4 Middle East and Africa Cannabidiol Market (2019-2035) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grant Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Product/Service
15.5 Analysis by Funding Institute
15.6 Analysis by Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership and Collaborations
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.2 Charlotte's Web, Inc.
18.2.1 Financial Analysis
18.2.2 Product/Service Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Developments
18.2.5 Certifications
18.3 Medical Marijuana, Inc.
18.3.1 Financial Analysis
18.3.2 Product/Service Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Developments
18.3.5 Certifications
18.4 CV Sciences, Inc.
18.4.1 Financial Analysis
18.4.2 Product/Service Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Developments
18.4.5 Certifications
18.5 Endoca BV
18.5.1 Financial Analysis
18.5.2 Product/Service Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Developments
18.5.5 Certifications
18.6 Gaia Herbs, Inc.
18.6.1 Financial Analysis
18.6.2 Product/Service Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Developments
18.6.5 Certifications
18.7 CBD Store
18.7.1 Financial Analysis
18.7.2 Product/Service Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Developments
18.7.5 Certifications
18.8 Medterra CBD, LLC
18.8.1 Financial Analysis
18.8.2 Product/Service Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Developments
18.8.5 Certifications
18.9 Anthology Brands
18.9.1 Financial Analysis
18.9.2 Product/Service Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Developments
18.9.5 Certifications
18.10 The CBDistillery
18.10.1 Financial Analysis
18.10.2 Product/Service Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Developments
18.10.5 Certifications
18.11 NuLeaf Naturals, LLC
18.11.1 Financial Analysis
18.11.2 Product/Service Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Developments
18.11.5 Certifications
19 Global Cannabidiol Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Charlotte’s Web Inc.
  • Medical Marijuana, Inc.
  • CV Sciences Inc.
  • Endoca BV